- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fischer's Cascella steps down
Fischer Imaging president and COORoberto A. Cascella has left the company, Fischer announced lastweek. Cascella left the Denver-based developer of x-ray and mammographysystems to pursue other interests, the company said. Fischer chairmanand CEO Morgan W.
Fischer Imaging president and COORoberto A. Cascella has left the company, Fischer announced lastweek. Cascella left the Denver-based developer of x-ray and mammographysystems to pursue other interests, the company said. Fischer chairmanand CEO Morgan W. Nields will assume Cascella's responsibilitiesuntil a successor is named. Cascella was with Fischer for eightyears.
Fischer also announced that Charles L. Dumas has joined thecompany as vice president of operations, with responsibility foroverseeing Fischer's manufacturing facilities. Before joiningFischer, Dumas was operations vice president and general managerof Genicom's desktop printer business.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
